POON Chiu Yee, Liona

Current Position:
Professor (Clinical)

Office Phone:
(852) 3505 1290

Email:
liona.poon@cuhk.edu.hk

 

Biographical details
Liona Poon was awarded MBBS from University of London in 2002 and undertook her specialty training in Obstetrics and Gynaecology in London. She gained a 3-year training fellowship from the Fetal Medicine Foundation and during this time, established a major screening programme for early detection of preeclampsia, which led to a Doctorate of Medicine (Research) in 2011. She then undertook subspecialty training in maternal fetal medicine at Imperial College Healthcare NHS Trust and King’s College Hospital NHS Foundation Trust with Mr TG Teoh and Professor KH Nicolaides as supervisors.

Qualifications:
MBBS (University of London), MRCOG, MD(Res) (University of London), Cert RCOG (Maternal and Fetal Medicine)

Research interests:
Her main research interests are in the prediction and prevention of maternal and perinatal morbidity and mortality. These include developing screening models for the prediction of aneuploidies, preeclampsia, fetal growth restriction, gestational diabetes, macrosomia, stillbirth, spontaneous preterm birth and induced labour. She is currently conducting a pan-European multicentre randomised controlled trial of Aspirin vs. placebo in the prevention of preterm preeclampsia (ASPRE), which is funded by the EC FP7 scheme. She has authored over 100 peer-reviewed publications in the top quartile of international journals in the field of Obstetrics and Gynaecology and Hypertension.

Grants:
EC FP7 (601852-2), NIHR EME (14/01/02), NIHR HTA (14/158), CUHK Start-up Support Fund, HK O&G Trust Fund

 

1Effective aspirin treatment of women at risk for preeclampsia delays the metabolic clock of gestation
Li X, Milosavljevic A, Elsea SH, Wang CC, Scaglia F, Syngelaki A, Nicolaides KH, Poon LC
Hypertension. 2021 Nov;78(5):1398-1410
2Novel ratio soluble fms-like tyrosine kinase-1/Angiotensin-II (sFlt-1/ANG-II) in pregnant women is associated with critical illness in COVID-19
Espino-y-Sosa S, Martinez-Portilla RJ, Torres-Torres J, Mario Solis, Paredes J, Estrada-Gutierrez G, Hernandez-Pacheco AN, Espejel-Nuñez A, Mateu-Rogell P, Juarez-Reyes A, Lopez-Ceh FE, Villafan-Bernal JR, Rojas-Zepeda L, Guzman-Guzman IP, Poon LC
Viruses 2021 Oct; 13(10): 1906
3A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics)
Poon LC, Magee LA, Verlohren S, Shennan A, von Dadelszen P, Sheiner E, Hadar E, Visser G, Costa FD, Kapur A, McAuliffe F, Nazareth A, Tahlak M, Kihara AB, Divakar H, McIntyre HD, Berghella V, Yang HX, Romero R, Nicolaides KH, Melamed N, Hod M
Int J Gynaecol Obstet. 2021 Jul;154 Suppl 1:3-31
4Outcome of radiofrequency ablation for selective fetal reduction before vs at or after 16 gestational weeks in complicated monochorionic pregnancy
Ting YH, Poon LCY, Tse WT, Chung MY, Wah YM, Hui ASY, Law KM, Chaemsaithong P, Leung TY
Ultrasound Obstet Gynecol. 2021 Aug;58(2):214-220
5Impact of replacing or adding placental growth factor on Down syndrome screening: A prospective cohort study
Sin AWT, Poon LC, Chaemsaithong P, Wah IYM, Hui ASY, Ting YH, Law KM, Leung TY, Sahota DS
Prenat Diagn. 2021 Aug;41(9):1111-1117
6Bronchopulmonary sequestration successfully treated with prenatal radiofrequency ablation of the feeding artery
Tse WT, Poon LC, Wah YM, Hui ASY, Ting YH, Leung TY
Ultrasound Obstet Gynecol. 2021 Aug;58(2):325-327
7Pregnancy and neonatal outcomes in COVID-19: study protocol for a global registry of women with suspected or confirmed SARS-CoV-2 infection in pregnancy and their neonates, understanding natural history to guide treatment and prevention
Banerjee J, Mullins E, Townson J, Playle R, Shaw C, Kirby N, Munnery K, Bourne T, Teoh TG, Dhanjal M, Poon L, Wright A, Lees C
BMJ Open. 2021 Jan 29;11(1):e041247
8Young pregnant women are also at an increased risk of mortality and severe illness due to coronavirus disease 2019: Analysis of the Mexican National Surveillance Program
Martinez Portilla RJ, Smith ER, He S, Torres JT, Espino-Y-Sosa S, Solis-Paredes JM, Poon LC
Am J Obstet Gynecol. 2021 Apr;224(4):404-407
9Preeclampsia: Universal Screening or Universal Prevention for Low and Middle-Income Settings?
Rolnik DL, Carvalho MHB, Lobo GAR, Verlohren S, Poon L, Baschat A, Hyett J, Thilaganathan B, Bujold E, Costa FDS
Rev Bras Ginecol Obstet. 2021 Apr;43(4):334-338
10The Use of Somatex Shunt for Fetal Pleural Effusion: A Cohort of 8 Procedures
Chung MY, Leung WC, Tse WT, Ting YH, Law KM, Hui ASY, Wah YM, Lam HS, Poon LCY, Leung TY
Fetal Diagn Ther. 2021;48(6):440-447
11Update on diagnosis of hyperglycemia in pregnancy and gestational diabetes mellitus from FIGO’s Pregnancy & Non- Communicable Diseases Committee
Poon LC, Hod M, McIntyre HD, Oats JJN, Kihara AB, Divakar H, Kapur A
Int J Gynaecol Obstet. 2021 Aug;154(2):189-194
12Cost-utility of a first-trimester screening strategy versus the standard of care for nulliparous women to prevent preterm preeclampsia in Belgium
Dubon Garcia A, Devlieger R, Redekop K, Vandeweyer K, Verlohren S, Poon LC
Pregnancy Hypertens. 2021 Jul 1;25:219-224
13Application of an individualized nomogram in first-trimester screening for trisomy 21
Sun Y, Zhang L, Dong D, Li X, Wang J, Yin C, Poon LC, Tian J, Wu Q
Ultrasound Obstet Gynecol. 2021 Jul;58(1):56-66
14Prediction of spontaneous preterm birth by cervical length in the first trimester of pregnancy: comparison of two measurement methods
Feng Q, Duan H, Ju X, Appiah K, Yip KM, Tai Y, Sun Q, Chaemsaithong P, Poon LC
Acta Obstet Gynecol Scand. 2021 Jul;100(7):1305-1312
15Accuracy of the FMF Bayes theorem-based model for predicting preeclampsia at 11-13 weeks of gestation in a Japanese population
Goto M, Koide K, Tokunaka M, Takita H, Hamada S, Nakamura M, Matsuoka Ryu, Sekizawa A, Poon LC
Hypertens Res. 2021 Jun;44(6):685-691
16Relationship between viral load, infection-to-delivery interval and mother-to-child transfer of anti-SARS-CoV-2 antibodies
Poon LC, Leung BW, Ma T, Yu FN, Kong CW, Lo TK, So PL, Leung WC, Shu W, Cheung KW, Moungmaithong S, Wang CC
Ultrasound Obstet Gynecol. 2021 Jun;57(6):974-978
17Equity in coronavirus disease 2019 vaccine development and deployment
Modi N, Ayres-de-Campos D, Bancalari E, Benders M, Briana D, Di Renzo GC, Fonseca EB, Hod M, Poon L, Cortes MS, Simeoni U, Tscherning C, Vento M, Visser GHA, Voto L
Am J Obstet Gynecol. 2021 May;224(5):423-427
18Doppler-based predictive model for methotrexate resistancein low-risk gestational trophoblastic neoplasia withmyometrial invasion: prospective study of 147 patients
Qin J, Zhang S, Poon L, Pan Z, Luo J, Yu N, Wang L, Wu X, Cheng X, Xie X, Lu Y, Lu W
Ultrasound Obstet Gynecol. 2021 May;57(5):829-839
19FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction
Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F, Berghella V, Nazareth A, Tahlak M, McIntyre HD, Costa FD, Kihara AB, Hadar E, McAuliffe F, Hanson M, Ma RC, Gooden R, Sheiner E, Kapur A, Divakar H, Ayres-de-Campos D, Hiersch L, Poon LC, Kingdom J, Romero R, Hod M
Int J Gynaecol Obstet. 2021 Mar;152 Suppl 1:3-57
20Genome-wide detection of cytosine methylation by single molecule real-time sequencing
Tse OYO, Jiang P, Cheng SH, Peng W, Shang H, Wong J, Chan SL, Poon LCY, Leung TY, Chan KCA, Chiu RWK, Lo YMD
Proc Natl Acad Sci U S A. 2021 Feb 2;118(5):e2019768118
21Omics and perinatal medicine Preeclampsia
Chaemsaithong P, Poon LC
In:  New Technologies and Perinatal Medicine: Prediction and Prevention of Pregnancy Complications
CRC Press, 2019 Dec, Ch25
22Scientific effort in combating COVID‐19 in obstetrics and gynecology
Martinez-Portilla RJ, Gil MM, Poon LC
Ultrasound Obstet Gynecol. 2021 Feb;57(2):189-194
23Pregnant women with SARS-CoV-2 infection are at higher risk of death and severe pneumonia: propensity score-matched analysis of a nationwide prospective cohort study (COV19Mx)
Martinez‐Portilla RJ, Sotiriadis A, Chatzakis C, Torres‐Torres J, Espino Y Sosa S, Sandoval‐Mandujano K, Castro‐Bernabe DA, Medina‐Jimenez V, Monarrez‐Martin JC, Figueras F, Poon LC
Ultrasound Obstet Gynecol. 2021 Feb;57(2):224-231
24Pregnant women with SARS-CoV-2 infection are at higher risk of death and severe pneumonia: propensity score-matched analysis of a nationwide prospective cohort study (COV19Mx)
Martinez‐Portilla RJ, Sotiriadis A, Chatzakis C, Torres‐Torres J, Espino Y Sosa S, Sandoval‐Mandujano K, Castro‐Bernabe DA, Medina‐Jimenez V , Monarrez‐Martin JC, Figueras F, Poon LC
Ultrasound Obstet Gynecol. 2021 Feb;57(2):224-231
25Single-cell RNA expression profiling of SARS-CoV-2-related ACE2 and TMPRSS2 in human trophectoderm and placenta
Cui D, Liu Y, Jiang X, Ding C, Poon LC, Wang H, Yang H
Ultrasound Obstet Gynecol. 2021 Feb;57(2):248-256
26Comparison of uterine artery Doppler measurements at 6 weeks of pregnancy after IVF between pregnancies that resulted in miscarriage and ongoing pregnancies
Guo J, Chaemsaithong P, Huang J, Chung JPW, Huang J, Poon LCY, Li TC
Int J Gynaecol Obstet. 2021 Feb;152(2):249-255
27The significance of low first trimester serum progesterone in ongoing early pregnancies presenting as pregnancies of unknown location
Ucyigit A, Fuller JL, Poon LC, J Johns, Ross JA
Eur J Obstet Gynecol Reprod Biol. 2021 Jan 12;258:294-298
28ISUOG Safety Committee Position Statement: safe performance of obstetric and gynecological scans and equipment cleaning in the context of COVID-19 (opinion)
Poon LC, Abramowicz JS, Dall'Asta A, Sande R, Ter Haar G, Maršal K, Brezinka C, Miloro P, Basseal J, Westerway SC, Abu-Rustum RS, Lees C
Ultrasound Obstet Gynecol. 2020 May,55(5):709-712
29Does Low-Dose Aspirin Initiated Before 11 Weeks' Gestation Reduce the Rate of Preeclampsia? (COMMENT)
Chaemsaithong P, Cuenca-Gomez D, Plana MN, Gil MM, Poon LC
Obstetrical & Gynecological Survey. 2020 Oct ;75(10):581-582
30Bradycardia-to-delivery interval and fetal outcomes in umbilical cord prolapse
Wong L, Tse WT, Lai CY, Hui ASY, Chaemsaithong P, Sahota DS, Poon LC, Leung TY
Acta Obstet Gynecol Scand. 2021 Jan;100(1):170-177
31Feasibility, Reliability and Agreement of Transperineal Ultrasound Measurement: Result from a Longitudinal Cohort Study
Kwan AHW, Chaemsaithong P, Tse WT, Appiah K, Chong KC, Leung TY, Poon LC
Fetal Diagn Ther 2020 Oct;47(10):721–730
32Monochorionic twins with selective fetal growth restriction: insight from placental whole transcriptome analysis
LI W, Chung CYL, Wang CC, Chan TF, Leung MBW, Chan OK, Wu L, APPIAH K, Chaemsaithong P, Cheng YKY, Poon LCY, Leung TY
Am J Obstet Gynecol. 2020 Nov;223(5):749.e1-749.e16
33Shear-wave sonoelastographic assessment of cervix in pregnancy
Duan H, Chaemsaithong P, Ju X, Ho SYS, Sun Q, Tai Y, Leung TY, Poon LC
Acta Obstet Gynecol Scand. 2020 Nov;99(11):1458-1468   
34Risk factors for anxiety and depression among pregnant women during the COVID-19 pandemic A web-based cross-sectional survey
Kajdy A, Feduniw S, Ajdacka U, Modzelewski J, Baranowska B, Sys D, Pokropek A, Pawlicka P, Kazmierczak M, Rabijewski M, Jasiak H, Lewandowska R, Borowski D, Kwiatkowski S, Poon LC                                        
Medicine (Baltimore). 2020 Jul 24;99(30):e21279        
35Detection and characterization of jagged ends of double-stranded DNA in plasma
Jiang P, Xie T, Ding SC, Zhou Z, Cheng SH, Chan RWY, Lee WS, Peng W, Wong J, Wong VWS, Chan HL, Chan SL, Poon LC, Leung TY, Chan AKC, Chiu RWK, Lo DYM
Genome Res. 2020 Aug;30(8):1144-1153                               
36ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction
Lees CC, Stampalija T, Baschat A, da Silva Costa F, Ferrazzi E, Figueras F, Hecher K, Kingdom J, Poon LC, Salomon LJ, Unterscheider J              
Ultrasound Obstet Gynecol. 2020 Aug;56(2):298-312                          
37First-trimester pre-eclampsia biomarker profiles in Asian population: a multicenter cohort study
Chaemsaithong P, Sahota D, Pooh RK, Zheng M, Ma R, Chaiyasit N, Koide K, Shaw SW, Seshadri S, Choolani M, Panchalee T, Yapan P, Sim WS, Sekizawa A, Hu Y, Shiozaki A, Saito S, Leung TY, Poon LC
Ultrasound Obstet Gynecol. 2020 Aug;56(2):206-214
38The effect of race on longitudinal maternal central hemodynamics
Ling HZ, Garcia Jara P, Bisquera A, Poon LC, Nicolaides K, Kametas NA
Ultrasound Obstet Gynecol. 2020 Jul;56(1):37-43     
39Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review
Juan J, Gil MM, Rong Z, Zhang Y, Yang H, Poon LC     
Ultrasound Obstet Gynecol. 2020 Jul;56(1):15-27
40ISUOG Interim Guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium: information for healthcare professionals - an update (INTERIM GUIDANCE)
Poon LC, Yang H, Dumont S, Lee JCS, Copel JA, Danneels L, Wright A, Costa FD, Leung TY, Zhang Y, Chen D, Prefumo F
Ultrasound Obstet Gynecol. 2020 Jun;55(6):848-862
41Maternal cardiac function in women at high-risk for pre-eclampsia treated with 150 mg aspirin or placebo: an observational study
Ling HZ, Jara PG, Bisquera A, Poon LC, Nicolaides KH, Kametas NA
BJOG. 2020 Jul;127(8):1018-1025
42ISUOG Safety Committee Position Statement on use of personal protective equipment and hazard mitigation in relation to SARS-CoV-2 for practitioners undertaking obstetric and gynecological ultrasound (opinion)
Abramowicz JS, Basseal JM, Brezinka C, Dall'Asta A, Deng J, Harrison G, Lee JCS, Lim A, Maršal K, Miloro P, Poon LC, Salvesen KÅ, Sande R, Ter Haar G, Westerway SC, Xie MX, Lees C
Ultrasound Obstet Gynecol. 2020 Jun;55(6):886-891
43Intrauterine vertical transmission of SARS-CoV-2: what we know so far (opinion)
Wang C, Zhou YH, Yang HX, Poon LC     
Ultrasound Obstet Gynecol. 2020 Jun;55(6):724-725
44Global interim guidance on coronavirus disease 2019 (COVID-19) during pregnancy and puerperium from FIGO and allied partners: Information for healthcare professionals (guideline)
Poon LC, Yang H, Kapur A, Melamed N, Dao B, Divakar H, David McIntyre H, Kihara AB, Ayres-de-Campos D, Ferrazzi EM, Carlo Di Renzo G, Hod M    
Int J Gynaecol Obstet. 2020 Jun;149(3):273-286
45ISUOG Consensus Statement on organization of routine and specialist obstetric ultrasound services in the context of COVID-19. (opinion)
Abu-Rustum RS, Akolekar R, Sotiriadis A, Salomon LJ, Da Silva Costa F, Wu Q, Frusca T, Bilardo CM, Prefumo F, Poon LC
Ultrasound Obstet Gynecol. 2020 Jun;55(6):863-870
46Coronavirus disease 2019 (COVID-19) in pregnant women: A report based on 116 cases       
Yan J, Guo J, Fan C, Juan J, Yu X, Li J, Feng L, Li C, Chen H, Qiao Y, Lei D, Wang C, Xiong G, Xiao F, He W, Pang Q, Hu X, Wang S, Chen D, Zhang Y, Poon LC, Yang H      
Am J Obstet Gynecol. 2020 Apr 23;223(1):111.e1-111.e14
47Why we should not stop giving aspirin to pregnantwomen during the COVID-19 pandemic (Letters to editor)
Kwiatkowski S, Borowski D, Kajdy A, Poon LC, Rokita W, Wielgos M                
Ultrasound Obstet Gynecol. 2020 Jun;55(6):841-843
48Novel coronavirus infection and pregnancy
Yang H, Wang C, Poon LC
Ultrasound Obstet Gynecol. 2020 Apr;55(4):435-437
49ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals
Poon LC, Yang H, Lee JCS, Copel JA, Leung TY, Zhang Y, Chen D, Prefumo F
Ultrasound Obstet Gynecol. 2020 May;55(5):700-708
50Plasma DNA end motif profiling as a fragmentomic marker in cancer, pregnancy and Transplantation
Jiang P, Sun K, Peng W, Cheng SH, Ni M, Yeung PC, Heung MMS, Xie T, Shang H, Zhou Z, Chan RWY, Wong J, Wong VWS, Poon LC, Leung TY, Lam WKJ, Chan JYK, Chan HLY, Chan KCA, Chiu RWK, Lo YMD
Cancer Discov. 2020 May;10(5):664-673
51Does low-dose aspirin initiated before 11 weeks’ gestation reduce the rate of preeclampsia?
Chaemsaithong P, Cuenca-Gomez D, Plana MN, Gil MM, Poon LC
Am J Obstet Gynecol. 2020 May;222(5):437-450
52Prevention of Spontaneous Preterm Birth
Appiah K, Chaemsaithong P, Poon LC    
MIMS JPOG 2019 ; 45 (4); 169-176
53Placental microRNA dataset of monochorionic twin pregnancies with and without selective fetal growth restriction
Meng M, Cheng YKK, Wu L, Chaemsaithong P, Leung MBW, Chim SSC, Sahota DS, Li W, Poon LC, Wang CC, Leung TY
Data in Breif Volume 30, June 2020, 105403
54Whole genome miRNA profiling revealed miR-199a as potential placental pathogenesis of selective fetal growth restriction in monochorionic twin pregnancies
Meng M, Cheng YKK, Wu L, Chaemsaithong P, Leung MBW, Chim SSC, Sahota DS, Li W, Poon LC, Wang CC, Leung TY
Placenta Volume 92, March 2020, Pages 44-53
55The predictive value of cervical shear wave elastography in the outcome of labor induction
Lu J, Cheng YKY, Ho SYS, Sahota DS, Hui LL, Poon LC, Leung TY
Acta Obstet Gynecol Scand. 2020 Jan;99(1):59-68
56From first-trimester screening to risk stratification of evolving pre-eclampsia in second and third trimesters of pregnancy: comprehensive approach
Poon LC, Galindo A, Surbek D, Chantraine F, Stepan H, Hyett J, Tan KH, Verlohren S
Ultrasound Obstet Gynecol. 2020 Jan;55(1):5-12
57Reasons for accepting or declining participation in the ASPRE trial: A qualitative study with women at high-risk of preterm-PE
Nikčević AV, Dodd Z, Prior J, O’Gorman N, Poon LC, Nicolaides KH
Prenat Diagn. 2019 Nov;39(12):1127-1135
58Erratum to "The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention"
Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, da Silva Costa F, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D'Alton M, Berghella V, Nicolaides KH, Hod M
Int J Gynaecol Obstet. 2019 Sep;146(3):390-391
59The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention. (FIGO COMMITTEE REPORT)
Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, Costa FD, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D'Alton M, Berghella V, Nicolaides KH, Hod M, Hod M
Int J Gynaecol Obstet. 2019 May;145 Suppl 1:1-33
60FIGO (International Federation of Gynecology and Obstetrics) Postpregnancy Initiative: Long-term maternal implications of pregnancy complications-follow-up considerations.
Sheiner E, Kapur A, Retnakaran R, Hadar E, Poon LC, Mclntyre HD, Divakar H, Staff AC, Narula J, Kihara AB, Hod M.
Int J Gynaecol Obstet 2019 Sep;147:1-31
61Clinical evaluation of a first trimester pregnancy algorithm predicting the risk of small for gestational age neonates
Graham K, Park F, McLennan A, Pelosi M, Williams P, Poon LC, Hyett J
Aust N Z J Obstet Gynaecol. 2019 Oct;59(5):670-676
62Prenatal visualization of paraumbilical veins in fetus with intra-abdominal umbilical vein stricture and intrauterine growth restriction
Chan YM, Law KM, Poon LC, Leung TY
Ultrasound Obstet Gynecol. 2019 Nov;54(5):697-698
63Inter-manufacturer comparison of automated immunoassays for the measurement of soluble FMS-like tyrosine kinase-1 and placental growth factor
Cheng YKY, Poon LC, Shennan A, Leung TY, Sahota DS
Pregnancy Hypertens. 2019 Jul;17:165-171
64Maternal hemodynamics in screen-positive and screen-negative women of the ASPRE trial
Ling HZ, Guy GP, Bisquera A, Poon LC, Nicolaides KH, Kametas NA
Ultrasound Obstet Gynecol. 2019 Jul;54(1):51-57
65Reproductive outcomes after surgical treatment of asherman syndrome: A systematic review
Guo EJ, Chung JPW, Poon LC, Li TC
Best Pract Res Clin Obstet Gynaecol. 2019 Aug;59:98-114
66Transvaginal three-dimensional assessment of Sylvian fissures at 18-30 weeks’ gestation
Poon LC, Sahota DS, Chaemsaithong P, Nakamura T, Machida M, Naruse K, Wah YM, Leung TY, Pooh RK
Ultrasound Obstet Gynecol. 2019 Aug;54(2):190-198
67Increased Sylvian fissure angle as early sonographic sign of malformation of cortical development
Pooh RK, Machida M, Nakamura T, Uenishi K, Chiyo H, Itoh K, Yoshimatsu J, Ueda H, Ogo K, Chaemsaithong P, Poon LC
Ultrasound Obstet Gynecol. 2019 Aug;54(2):199-206
68Good clinical practice advice: First trimester screening and prevention of pre- eclampsia in singleton pregnancy FIGO Working Group on Good Clinical Practice in Maternal–Fetal Medicine
Poon LC
Int J Gynaecol Obstet. 2019 Mar;144(3):325-329
69Do specific ultrasonography features identified at the time of early pregnancy loss predict fetal chromosomal abnormality?  A systematic review and meta-analysis
Huang J, Zhu W, Tang J, Saravelos SH, Poon LC, Li TC
Genes Dis. 2019 Jun 6(2):129-137
70The International Federation of Gynecology and Obstetrics (FIGO) initiative on pre-eclampsia: A pragmatic guide for first-trimester screening and prevention.
Poon LC, Shennan A, Hyett JA, Kapur A, Hadar E, Divakar H, McAuliffe F, Costa FD, von Dadelszen P, McIntyre HD, Kihara AB, Di Renzo GC, Romero R, D'Alton M, Berghella V, Nicolaides KH, Hod M, Hod M
Int J Gynaecol Obstet. 2019 May;145 Suppl 1:1-33
71Screening and prevention of pre-eclampsia: a review
Chaemsaithong P , Appiah EK , Sahota DS , Leung TY, Poon LC
Hong Kong J Gynaecol Obstet Midwifery 2019;19(1):56-72
72Factors that affect ultrasound-determined labor progress in women undergoing induction of labor
Chaemsaithong P, Kwan AHW, Tse WT, Lim WT, Chan WWY, Chong KC, Leung TY, Poon LC
Am J Obstet Gynecol. 2019 Jun;220(6):592.e1-592.e15
73Pre-induction transperineal ultrasound assessment for the prediction of labor outcome
Chan WWY, Chaemsaithong P, Lim WT, Tse WT, Kwan AHW, Leung TY, Sahota D, Poon LC
Fetal Diagn Ther. 2019 Apr;45(4):256-267
74Impact of preimplantation genetic testing for aneuploidy on obstetrical practice
Chan YM, Li TC, Poon LC
Curr Opin Obstet Gynecol. 2019 Apr;31(2):127-131
75Body mass index at 11–13 weeks’ gestation and pregnancy complications in a Southern Chinese population: a retrospective cohort study
Chaemsaithong P, Leung TY, Sahota DS, Cheng YKY, Leung WC, Lo TK, Poon LC
J Matern Fetal Neonatal Med. 2019 Jun;32(12):2056-2068
76Comment on "First Trimester screening for early and late preeclampsia based on maternal characteristics, biophysical parameters, and angiogenic factors"
Sahota DS, Poon LC
Prenat Diagn. 2018 Oct;38(11):891, 1 page
77Updates on Screening, Prevention, Treatment, and Genetic Markers for Preeclampsia
Palomaki GE, Martin JN Jr, Karumanchi SA, Poon LC
Clin Chem. 2018 Dec;64(12):1684-1689
78Objective assessment of the fetal facial profile at second and third trimester of pregnancy
Lu J, Sahota DS, Poon LC, Ting YH, Cheng YKY, Wang Y, Leung TY
Prenat Diagn. 2019 Jan;39(2):107-115
79The first-trimester of pregnancy - a window of opportunity for prediction and prevention of pregnancy complications and future life  
Poon LC, McIntyre HD, Hyett JA, da Fonseca EB, Hod M
Diabetes Res Clin Pract. 2018 Nov;145:20-30
80Maternal hemodynamics, fetal biometry and Doppler indices in pregnancies followed up for suspected fetal growth restriction
Roberts LA, Ling HZ, Poon LC, Nicolaides KH, Kametas NA
Ultrasound Obstet Gynecol. 2018 Oct;52(4):507-514
81Transverse technique: complementary approach to measurement of first-trimester uterine artery Doppler
Drouin O, Johnson J, Metcalfe A, Huber J, Schwarzenberger J,  Winters E, Stavness L, Chaemsaithong P, Tse AWT, Lu J, Lim WT, Leung TY, Bujold E, Sahota D, Poon LC
Ultrasound Obstet Gynecol. 2018 Nov;52(5):639-647
82Prediction of labor outcome using serial transperineal ultrasound in the first stage of labor
Chor CM, Poon LC, Leung TY
J Matern Fetal Neonatal Med. 2019 Jan;32(1):31-37
83Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE
Tan MY, Poon LC, Rolnik DL, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Greco E, Papaioannou G, Wright D, Nicolaides KH
Ultrasound Obstet Gynecol. 2018 Jul;52(1):52-59
84Uterine artery pulsatility index in the first trimester: assessment of intersonographer and intersampling site measurement differences
Chaemsaithong P, Ting YH, Cheng KYY, Poon LC, Leung TY, Sahota DS
J Matern Fetal Neonatal Med. 2018 Sep;31(17):2276-2283
85ASPRE trial: incidence of preterm pre-eclampsia in patients fulfilling ACOG and NICE criteria according to risk by FMF algorithm
Poon LC, Rolnik DL, Tan MY, Delgado JL, Tsokaki T, Akolekar R, Singh M, Andrade W, Efeturk T, Jani JC, Plasencia W, Papaioannou G, Blazquez AR, Carbone IF, Wright D, Nicolaides KH
Ultrasound Obstet Gynecol. 2018 Jun;51(6):738-742
86Effect of change in posture on maternal functional hemodynamics at 35–37 weeks’ gestation
Guy GP, Ling HZ, Machuca M, Poon LC, Nicolaides KH
Ultrasound Obstet Gynecol. 2018 Mar;51(3):368-374
87Aspirin for Evidence-Based Preeclampsia Prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia
Wright D, Poon LC, Rolnik DL, Syngelaki A, Delgado JL, Vojtassakova D, de Alvarado M, Kapeti E, Rehal A, Pazos A, Carbone IF, Dutemeyer V, Plasencia W, Papantoniou N, Nicolaides KH
Am J Obstet Gynecol. 2017 Dec;217(6):685.e1-685.e5
88Integrated Proteomic and Metabolomic prediction of Term Preeclampsia
Bahado-Singh R, Poon LC, Yilmaz A, Syngelaki A, Turkoglu O, Kumar P, Kirma J, Allos M, Accurti V, Li J, Zhao P, Graham SF, Cool DR, Nicolaides K
Sci Rep. 2017 Nov 23;7(1):16189 (Page 1-10)
89Impact of aspirin on trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks: a randomized controlled study . E. Scazzocchio, D. Oros, D. Diaz, J. C. Ramirez, M. Ricart, E. Meler, R. González de Agüero, E. Gratacos and F. Figueras
Poon LC
Ultrasound Obstet Gynecol. 2017 Apr;49(4):433
90Protocol for measurement of mean arterial pressure at 10–40 weeks’ gestation
Roberts L, Chaemsaithong P, Sahota DS, Nicolaides KH, Poon LC
Pregnancy Hypertens. 2017 Oct;10:155-160
91Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history
Poon LC, Wright D, Rolnik DL, Syngelaki A, Delgado JL, Tsokaki T, Leipold G, Akolekar R, Shearing S, De Stefani L, Jani JC, Plasencia W, Evangelinakis N, Gonzalez-Vanegas O, Persico N, Nicolaides KH
Am J Obstet Gynecol. 2017 Nov;217(5):585.e1-585.e5
92ASPRE trial: performance of screening for preterm pre-eclampsia
Rolnik DL, Wright D, Poon LC, Syngelaki A, O'Gorman N, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Nicolaides KH
Ultrasound Obstet Gynecol 2017 Oct;50(4):492-495
93Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE).
O'Gorman N, Wright D, Rolnik DL, Nicolaides KH, Poon LC
BMJ Open. 2016 Jun 28;6(6):e011801. doi: 10.1136/bmjopen-2016-011801.
94Protocol for the prospective validation study: 'Screening programme for pre-eclampsia' (SPREE)
Tan MY, Koutoulas L, Wright D, Nicolaides KH, Poon LC
Ultrasound Obstet Gynecol. 2017 Aug;50(2):175-179
95Metabolomic determination of pathogenesis of late-onset preeclampsia
Bahado-Singh RO, Syngelaki A, Mandal R, Graham SF, Akolekar R, Han B, Bjondahl TC, Dong E, Bauer S, Alpay-Savasan Z, Turkoglu O, Ogunyemi D, Poon LC, Wishart DS, Nicolaides KH
J Matern Fetal Neonatal Med. 2017 Mar;30(6):658-664
96Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Rolnik DL, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum-Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH
N Engl J Med. 2017 Aug 17;377(7):613-622
97Accuracy of competing-risks model in screening for pre-eclampsia by maternal factors and biomarkers at 11–13 weeks' gestation
O'Gorman N, Wright D, Poon LC, Rolnik DL, Syngelaki A, Wright A, Akolekar R, Cicero S, Janga D, Jani J, Molina F S, Paco Matallana C, Papantoniou N, Persico N, Plasencia W, Singh M, Nicolaides K H
Ultrasound Obstet Gynecol 2017 Jun;49(6):751-755
98Maternal cardiac function at 35-37 weeks' gestation: relationship with birth weight
Guy G.P., Ling H.Z., Machuca M., Poon LC, Nicolaides K.H.
Ultrasound Obstet Gynecol. 2017 Jan;49(1):67-72
99Maternal cardiac function at 35-37 weeks’ gestation: prediction of preeclampsia and gestational hypertension
Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH
Ultrasound in Obstetrics and Gynecology Jan 2017;49(1):61-66
100Maternal Cardiovascular Function at 35-37 Weeks' Gestation: Relation to Maternal Characteristics
Guy GP, Ling HZ, Garcia P, Poon LC, Nicolaides KH
Ultrasound in Obstetrics and Gynecology Jan 2017;49(1):39-45
101Birth weight in live births and stillbirths
Poon LC, Tan MY, Yerlikaya G, Syngelaki A, Nicolaides KH
Ultrasound Obstet Gynecol Nov 2016;48(5):602-606
102Metabolomic Determination of Pathogenesis of Late-onset Preeclampsia.
Bahado-Singh RO, Syngelaki A, Mandal R, Akolekar R, Han B, Bjondahl TC, Dong E, Bauer S, Alpay-Savasan Z, Graham S, Turkoglu O, Ogunyemi D, Poon LC, Wishart DS, Nicolaides KH.
Journal of Maternal Fetal and Neonatal Medicine 2016, J Matern Fetal Neonatal Med. 2016; 28: 1-7.
103Risk of preterm birth following treatment for cervical disease: Stakeholder meeting summary.
Sasieni P, Castanon A, Landy R, Kyrgiou M, Kitchener H, Quigley M, Poon LC, Shennan A, Paraskevaidis E, Hollingworth A, Soutter P, Freeman Wang T, Peebles D, Prendeville W, Patnick J.
British J Obstet Gynaecol 2015; doi: 10.1111/1471-0528.13839.
104Cervical Cerclage for Preterm Birth Prevention in Twin Gestations with Short Cervix: A Case-Control_ Study.
Houlihan C, Poon LC, Ciarlo M, Kim E, Guzman ER, Nicolaides KH.
Ultrasound Obstet Gynecol 2016, doi: 10.1002/uog.15918.
105Cervical pessary for prevention of preterm birth in singleton pregnancies with short cervical length: a multicentre, randomized controlled trial.
Nicolaides KH, Syngelaki A, Poon LC, Picciarelli G, Tul N, Zamprakou A, Skyfta E, Parra-Cordero M, Palma-Dias R, Rodriquez Calvo J.
New England Journal of Medicine 2016; 374:1044-52.
106Contingent Screening for Small by Weight for Gestational Age Neonates.
Frick AP, Nicolaides KH, Poon LC.
Pediatr Endocrinol Rev 2016;13:568-573.
107The use of ultrasound and other markers for early detection of preeclampsia.
O'Gorman N, Nicolaides KH, Poon LC.
Womens Health (Lond Engl) 2016;12:199-207.
108Clinical implementation of routine screening for fetal trisomies by the cell-free DNA test contingent on results from first-trimester combined test.
Gil MM, Revello R, Poon LC, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol 2016; 47:45-52.
109Prediction of large for gestational age neonates: Screening by maternal factors and biomarkers in the three trimesters of pregnancy.
Frick A, Syngelaki S, Zheng MM, Poon LC*, Nicolaides KH.
Ultrasound in Obstet Gynecol 2016;47:332-339.
110Current controversies in prenatal diagnosis 3: Is there still a Value in a Nuchal Translucency Screening Ultrasound in conjunction with Maternal Plasma Non-Invasive cell free DNA testing?’
Wilson RD, Poon LC, and Ghidini A.
Prenatal Diagnosis 2015; doi: 10.1002/pd.4719. [Epub ahead of print_]
111First trimester prediction of HELLP Syndrome.
Oliveira N, Poon LC, Nicolaides KH, Baschat AA.
Prenatal diagnosis 2016; 36:29-33.
112Clinical validation of the IONA® test for first-trimester detection of trisomy 21, 18 and 13.
Poon LC, Dumidrascu-Diris D, Francisco C, Fantasia I, Nicolaides KH.
Ultrasound Obstet Gynecol 2016; 47:184-187
113Cervical pessaries for prevention of preterm birth: a randomised controlled trial.
Nicolaides KH, Syngelaki A, Poon LC, De Paco C, Plasencia W, Molina F, Picciarelli G, Tul N, Celik E, Lau TK, Conturso R.
Am J Obstet Gynecol 2016, 214:3.e1-9
114The prediction of preterm birth in twin pregnancy: an individual patient level meta-analysis.
Kindinger LM, Poon LC, Cacciatore S, MacIntyre, Fox NS, Schuit E, Mol B, Liem S, Lim A, Hermans F, Serra V, Perales A, Darzi A, Bennett P, Nicolaides KH, Teoh TG.
British J Obstet Gynaecol 2016; 123:877-884.
115Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11-13 weeks’ gestation.
O’Gorman N, Wright D, Syngelaki A, Akolekar R, Wright A, Poon LC, Nicolaides KH.
Am J Obstet Gynecol 2015, pii: S0002-9378(15)00900-X. doi: 10.1016/j.ajog.2015.08.034. [Epub ahead of print_]
116Prediction of small for gestational age neonates: screening by biophysical and biochemical markers at 19-24 weeks.
Poon LC, Lesmes C, Gallo DM, Akolekar R, Nicolaides KH.
Ultrasound Obstet Gynecol. 2015 May 18. doi: 10.1002/uog.14904. [Epub ahead of print_]
117Poon L. Re: Prediction of early- and late-onset pregnancy-induced hypertension using placental volume on three-dimensional ultrasound and uterine artery Doppler.
T. Arakaki, J. Hasegawa, M. Nakamura, S. Hamada, M. Muramoto, H. Takita, K. Ichizuka and A. Sekizawa. Ultrasound Obstet Gynecol 2015; 45: 539-543.
Ultrasound Obstet Gynecol 2015;45:513.
118Prediction of small for gestational age neonates: Screening by maternal serum biochemical markers at 19-24 weeks.
Lesmes C, Gallo DM, Gonzalez R, Poon LC*, Nicolaides KH.
Ultrasound Obstet Gynecol. 2015 May 13. doi: 10.1002/uog.14899. [Epub ahead of print_]
119Prediction of small-for-gestational-age neonates: maternal biochemical markers at 30-34 weeks.
Bakalis S, Gallo DM, Mendez O, Poon LC*, Nicolaides KH.
Ultrasound Obstet Gynecol 2015; 46: 208-215.
120Prediction of small-for-gestational-age neonates: screening by biophysical and biochemical markers at 30-34 weeks.
Bakalis S, Peeva G, Gonzalez R, Poon LC*, Nicolaides KH.
Ultrasound Obstet Gynecol. 2015 Mar 31. doi: 10.1002/uog.14863. [Epub ahead of print_]
121Prediction of small-for-gestational-age neonates: screening by placental growth factor and soluble fms-like tyrosine kinase-1 at 35-37 weeks.
Fadigas C, Peeva G, Mendez O, Poon LC*, Nicolaides KH.
Ultrasound Obstet Gynecol 2015; 46: 191-197.
122Prediction of small for gestational age neonates: screening by uterine artery Doppler and mean arterial pressure at 19-24 weeks.
Lesmes C, Gallo DM, Saiid Y, Poon LC*, Nicolaides KH.
Ultrasound Obstet Gynecol. 2015 Mar 24. doi: 10.1002/uog.14855. [Epub ahead of print_]
123Prediction of small-for-gestational-age neonates: screening by uterine artery Doppler and mean arterial pressure at 35-37 weeks.
Fadigas C, Guerra L, Garcia-Tizon Larroca S, Poon LC*, Nicolaides KH.
Ultrasound Obstet Gynecol 2015; 45: 715-721.
124Umbilical and fetal middle cerebral artery Doppler at 35-37 weeks' gestation in the prediction of adverse perinatal outcome.
Akolekar R, Syngelaki A, Gallo DM, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2015; 46: 82-92.
125Prediction of small-for-gestational-age neonates: screening by fetal biometry at 35-37 weeks.
Fadigas C, Saiid Y, Gonzalez R, Poon LC*, Nicolaides KH.
Ultrasound Obstet Gynecol 2015; 45: 559-565.
126Competing risks model in screening for preeclampsia by maternal characteristics and medical history.
Wright D, Syngelaki A, Akolekar R, Poon LC, Nicolaides KH.
Am J Obstet Gynecol 2015; 213: 62.e1-62.e10.
127Prediction of small for gestational age neonates: screening by fetal biometry at 19-24 weeks.
Lesmes C, Gallo D, Panaiotova J, Poon LC*, Nicolaides KH.
Ultrasound Obstet Gynecol 2015; 46: 198-207.
128Umbilical and fetal middle cerebral artery Doppler at 30-34 weeks' gestation in the prediction of adverse perinatal outcome.
Bakalis S, Akolekar R, Gallo DM, Poon LC*, Nicolaides KH.
Ultrasound Obstet Gynecol 2015; 45: 409-420.
129Prediction of small for gestational age neonates: Screening by uterine artery Doppler and mean arterial pressure at 30-34 weeks.
Bakalis S, Stoilov B, Akolekar R, Poon LC*, Nicolaides KH.
Ultrasound Obstet Gynecol 2015; 45: 707-714.
130Mean arterial pressure in the three trimesters of pregnancy: effects of maternal characteristics and medical history.
Wright A, Wright D, Ispas CA, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2015; 45: 698-706.
131Prediction of small for gestational age neonates: screening by fetal biometry at 30-34 weeks.
Bakalis S, Silva M, Akolekar R, Poon LC*, Nicolaides KH.
Ultrasound Obstet Gynecol 2015; 45: 551-558.
132UK NHS pilot study on cell-free DNA testing in screening for fetal trisomies: Factors affecting uptake.
Gil MM, Giunta G, Macalli EA, Poon LC, Nicolaides KH.
Ultrasound Obstet Gynecol 2015; 45: 67-73.
133Fetal fraction in maternal plasma cell-free DNA in the prediction of spontaneous preterm delivery.
Quezada MS, Francisco C, Dumitrascu-Biris D, Nicolaides KH, Poon LC*.
Ultrasound Obstet Gynecol 2015; 45: 101-105.
134Maternal plasma cell-free DNA in the prediction of preeclampsia.
Rolnik DL, O’Gorman N, Fiolna M, van den Boom D, Nicolaides KH, Poon LC*.
Ultrasound Obstet Gynecol 2015; 45: 106-111.
135Early prediction of preeclampsia.
Poon LC, Nicolaides KH.
Obstet Gynecol Int. 2014; 2014: 297397.
136Management of hypertriglyceridaemia-induced acute pancreatitis in pregnancy.
Amin T, Poon L, Teoh T, Moorthy K, Robinson S.
J Matern Fetal Neonatal Med. 2014 Jul 29:1-13. [Epub ahead of print_]
137Maternal serum anti-Müllerian hormone at 11-13 weeks' gestation in the prediction of preeclampsia.
Birdir C, Fryze J, Vasiliadis H, Nicolaides KH, Poon LC*.
J Matern Fetal Neonatal Med 2015; 28: 954-958.
138Competing risk model in screening for preeclampsia by mean arterial pressure and uterine artery pulsatility index at 30-33 weeks' gestation.
Tayyar A, Garcia-Tizon Larroca S, Poon LC, Wright D, Nicolaides KH.
Fetal Diagn Ther. 2014; 36: 18-27.
139Demographic factors that can be used to predict early-onset pre-eclampsia.
Leung C, Saaid R, Pedersen L, Park F, Poon L, Hyett J.
J Matern Fetal Neonatal Med 2015; 28: 535-539.
140First-trimester maternal factors and biomarker screening for preeclampsia.
Poon LC, Nicolaides KH.
Prenat Diagn 2014; 34: 618-627.
141Successful induction of labor: prediction by pre-induction cervical length, angle of progression and cervical elastography.
Pereira S, Frick AP, Poon LC, Zamprakou A, Nicolaides KH.
Ultrasound Obstet Gynecol 2014; 44: 468-475.
142Is High Fetal Nuchal Translucency Associated with Submicroscopic Chromosomal Abnormalities by Array CGH?
Huang J, Poon LC, Akolekar R, Choy KW, Leung TY, Nicolaides KH.
Ultrasound Obstet Gynecol 2014; 43: 620-624.
143Competing risks model in screening for preeclampsia by biophysical and biochemical markers at 30-33 weeks’ gestation.
Garcia-Tizon Larroca S, Tayyar A, Poon LC, Wright D, Nicolaides KH.
Fetal Diagn Ther 2014; 36: 9-17.
144Prediction of preeclampsia by mean arterial pressure at 11-13 and 20-24 weeks’ gestation.
Gallo D, Poon LC, Fernandez M, Wright D, Nicolaides KH.
Fetal Diagn Ther 2014; 36: 28-37.
145Competing risks model in screening for preeclampsia by serum placental growth factor and soluble fms-like tyrosine kinase-1 at 30-33 weeks’ gestation.
Lai J, Garcia-Tizon Larroca S, Peeva G, Poon LC, Wright D, Nicolaides KH.
Fetal Diagn Ther 2014; 35: 240-248.
146Optimal method and timing of intrauterine intervention in TRAP sequence: case study and meta-analysis.
Chaveeva P, Poon LC, Sotiriadis A, Kosinski P, Nicolaides KH.
Fetal Diagn Ther 2014; 35: 267-279.
147Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13, 20-24 and 30-34 weeks’ gestation in late onset preeclampsia and small for gestational age.
Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH.
Fetal Diagn Ther 2014; 35: 249-257.
148Maternal serum placental growth factor (PlGF) isoforms 1 and 2 at 11-13 weeks’ gestation in preeclampsia and small for gestational age.
Nucci M, Poon LC, Demirdjian G, Darbouret B, Nicolaides KH.
Fetal Diagn Therr 2014; 35: 249-257.
149Prediction of preeclampsia by uterine artery Doppler at 20-24 weeks’ gestation.
Gallo D, Poon LC, Akolekar R, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2013; 1: 241-247.
150Trichorionic and dichorionic triplet pregnancies at 10-14 weeks: Outcome after embryo reduction compared to expectant management.
Chaveeva P, Kosinski P, Puglia D, Poon L, Nicolaides K.
Fetal Diagn Ther 2013; 1: 199-205.
151First-trimester contingent screening for trisomies 21, 18 and 13 by biomarkers and maternal blood cell-free DNA testing.
Nicolaides KH, Syngelaki A, Poon LC, Gil M, Wright D.
Fetal Diagn Ther 2014; 35: 185-192.
152Clinical evaluation of a first trimester algorithm predicting the risk of hypertensive disease of pregnancy.
Park FJ, Leung CH, Poon LC, Williams PF, Rothwell SJ, Hyett JA.
Aust N Z J Obstet Gynaecol 2013; 53: 532-539.
153How feasible is expectant management of interstitial ectopic pregnancy?
Poon LC, Emmanuel E, Ross J, Johns J.
Ultrasound Obstet Gynecol 2013, Ultrasound Obstet Gynecol 2014; 43: 317-321.
154Association of placental perfusion, as assessed by magnetic resonance imaging and uterine artery Doppler ultrasound, and its relationship to pregnancy outcome.
Derwig I, Lythgoe DJ, Barker GJ, Poon L, Gowland P, Yeung R, Fernando Z, Nicolaides, KH.
Placenta 2013; 34: 885-891.
155First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell free DNA testing.
Nicolaides KH, Wright D, Poon L, Syngelaki A, Gil M.
Ultrasound Obstet Gynecol 2013; 42: 41-50.
156Second-trimester screening for trisomy 21 using prefrontal space ratio.
Chaveeva P, Agathokleous M, Poon LC, Markova D, Nicolaides KH.
Fetal Diagn Ther 2013; 34: 50-55.
157Maternal thyroid function at 11-13 weeks’ gestation in twin pregnancy.
Ashoor G, Muto O, Poon LC, Abdulla M, Nicolaides KH.
Thyroid 2013; 23: 1165-1171.
158Maternal serum cytokines at 30-33 weeks in the prediction of preeclampsia.
Mosimann B, Wagner M, Poon LC, Bansal AS, Nicolaides KH.
Prenatal Diagnosis 2013; 33: 823-830.
159Association of placental T2 relaxation times and uterine artery Doppler ultrasound measures of placental blood flow.
Derwig I, Barker GJ, Poon L, Zelaya F, Gowland P, Lythgoe DJ, Nicolaides KH.
Placenta 2013; 34: 474-479.
160Natural killer cells and their activation status in normal pregnancy.
Mosimann B, Wagner M, Shehata H, Poon LC, Ford B, Nicolaides KH, Bansal AS.
International Journal of Reproductive Medicine 2013; 2013: 906813.
161Maternal plasma cell-free fetal and maternal DNA at 11-13 weeks’ gestation: Relation to fetal and maternal characteristics and pregnancy outcomes.
Poon LC, Musci T, Song K, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2013; 33: 215-223.
162Maternal Serum Placental Growth Factor, Pregnancy-Associated Plasma Protein-A and Free β-Human Chorionic Gonadotrophin at 30-33 Weeks in the Prediction of Pre-Eclampsia.
Lai J, Pinas A, Poon LC, Agathokleous M, Nicolaides KH.
Fetal Diagn Ther 2013; 33: 164-172.
163Meta-analysis of second-trimester markers for trisomy 21.
Agathokleous M, Chaveeva P, Poon LC, Kosinski P, Nicolaides KH.
Ultrasound Obstet Gynecol 2013; 41: 247-261.
164Maternal serum tumour necrosis factor receptor 1 (TNF-R1) at 30-33 weeks in the prediction of preeclampsia.
Mosimann B, Wagner M, Birdir C, Poon LC, Nicolaides KH.
J Matern Fetal Neonatal Med 2013; 26: 763-767.
165Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks' gestation: relation to maternal and fetal characteristics.
Ashoor G, Syngelaki A, Poon L, Rezende J, Nicolaides K.
Ultrasound Obstet Gynecol 2013; 41: 26-32.
166Maternal serum retinol-binding protein-4 at 11-13 weeks’ gestation in normal and pathological pregnancies.
Nanda S, Nikoletakis G, Markova D, Poon LC, Nicolaides KH.
Metabolism 2013; 62: 814-819.
167Maternal serum activin-A at 30-33 weeks in the prediction of preeclampsia.
Lai J, Pinas A, Syngelaki A, Poon LC, Nicolaides KH.
J Matern Fetal Neonatal Med 2013; 26: 733-737.
168Mean arterial pressure, systolic and diastolic blood pressure at 30–33 weeks in the prediction of preeclampsia.
Lai J, Poon LC, Bakalis S, Markova D, Nicolaides KH.
Fetal Diagn Ther 2013; 33: 173-181.
169Uterine artery Doppler at 30–33 weeks’ gestation in the prediction of preeclampsia.
Lai J, Poon LC, Pinas A, Bakalis S, Nicolaides KH.
Fetal Diagn Ther 2013; 33: 156-163.
170Second-trimester uterine artery Doppler in the prediction of stillbirths.
Poon LC, Volpe N, Muto B, Yu CKH, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2013; 33: 28-35.
171Combined screening for preeclampsia and small for gestational age at 11–13 weeks.
Poon LC, Syngelaki A, Akolekar R, Lai J, Nicolaides KH.
Fetal Diagn Ther 2013; 33: 16-27.
172Competing risks model in early screening for preeclampsia by biophysical and biochemical markers.
Akolekar R, Syngelaki A, Poon LC, Wright D, Nicolaides KH.
Fetal Diagn Ther 2013; 33: 8-15.
173Maternal serum soluble endoglin (sEng) at 30-33 weeks in the prediction of preeclampsia.
Lai J, Syngelaki A, Poon LC, Nucci M, Nicolaides KH.
Fetal Diagn Ther 2013; 33: 149-155.
174A competing risks model in early screening for preeclampsia.
Wright D, Akolekar R, Syngelaki A, Poon LC, Nicolaides KH.
Fetal Diagn Ther 2012; 32: 171-178.
175Birthweight with gestation and maternal characteristics in live births and stillbirths.
Poon LC, Volpe N, Muto B, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2012; 32: 156-165.
176C-reactive protein at 11 to 13 weeks’ gestation in spontaneous early preterm delivery.
Bakalis S, Poon LC, Vayna AM, Pafilis I, Nicolaides KH.
J Matern Fetal Neonatal Med 2012; 25: 2475-2478.
177Maternal serum ferritin at 11 to 13 weeks’ gestation in spontaneous early preterm delivery.
Beta J, Poon LC, Bakalis S, Mosimann B, Nicolaides KH.
J Matern Fetal Neonatal Med 2012; 25:1852-1855.
178Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks’ gestation: Effect of maternal and fetal factors.
Ashoor G, Poon LC, Syngelaki A, Mosimann B, Nicolaides KH.
Fetal Diagn Ther 2012; 31: 237-243.
179First trimester screening for spontaneous preterm delivery with maternal characteristics and cervical length.
Greco E, Gupta R, Syngelaki A, Poon LC, Nicolaides KH.
Fetal Diagn Ther 2012; 31: 154-161.
180Protocol for measurement of mean arterial pressure at 11-13 weeks’ gestation.
Poon LC, Zymeri NA, Zamprakou A, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2012; 31: 42-48.
181First trimester screening for neural tube defects using AFP.
Bredaki FE, Poon LC, Birdir C, Escalante D, Nicolaides KH.
Fetal Diagn Ther 2012; 31: 109-114.
182Maternal serum resistin at 11-13 weeks’ gestation in normal and pathological pregnancies.
Nanda S, Poon LC, Muhaisen M, Acosta IC, Nicolaides KH.
Metabolism 2012; 61: 699-705.
183Large loop excision of transformation zone and cervical length in the prediction of spontaneous preterm delivery.
Poon LC, Savvas M, Zamblera D, Skyfta E, Nicolaides KH.
BJOG 2012; 119: 692-698.
184Systolic diastolic and mean arterial pressure at 11-13 weeks in the prediction of hypertensive disorders in pregnancy: a prospective screening study.
Poon LC, Kametas NA, Valencia C, Chelemen T, Nicolaides KH.
Hypertens Pregnancy 2011; 30: 93-107.
185First-trimester prediction of macrosomia.
Poon LC, Karagiannis G, Stratieva V, Syngelaki A, Nicolaides KH.
Fetal Diagn Ther 2011; 29: 139-147.
186Reference range of birth weight with gestation and first-trimester prediction of small for gestation neonates.
Poon LC, Karagiannis G, Staboulidou I, Shafiei A, Nicolaides KH.
Prenat Diagn 2011; 31: 58-65.
187Normal ranges of embryonic length, embryonic heart rate, gestational sac diameter and yolk sac diameter in early pregnancy.
Papaioannou GKI, Syngelaki A, Poon LC, Ross J, Nicolaides KH.
Fetal Diagn Ther 2010; 28: 207-219.
188Hypertensive disorders in pregnancy: Screening by biophysical and biochemical markers at 11-13 weeks.
Poon LC, Akolekar R, Lachmann R, Beta J, Nicolaides KH.
Ultrasound in Obstetrics and Gynecology 2010; 35: 662-670.
189Hypertensive disorders in pregnancy: combined screening by uterine artery Doppler, blood pressure and serum PAPP-A at 11-13 weeks.
Poon LC, Stratieva V, Piras S, Piri S, Nicolaides KH.
Prenat Diagn 2010; 30: 216-223.
190Hypertensive disorders in pregnancy: Screening by uterine artery Doppler and blood pressure at 11-13 weeks.
Poon LC, Karagiannis G, Leal A, Romero Infante X, Nicolaides KH.
Ultrasound in Obstetrics and Gynecology 2009; 34: 497-502.
191Hypertensive disorders in pregnancy: Screening by uterine artery Doppler at 11-13 weeks.
Poon LC, Staboulidou I, Maiz N, Plasencia W, Nicolaides KH.
Ultrasound in Obstetrics and Gynecology 2009; 34: 142-148.
192Maternal risk factors for hypertensive disorders in pregnancy: a multivariate approach.
Poon LC, Kametas NA, Chelemen T, Leal A, Nicolaides KH.
J Hum Hypertens 2010; 24: 104-110.
193First-trimester prediction of hypertensive disorders in pregnancy.
Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH.
Hypertension 2009; 53: 812-818.
194First-trimester maternal serum matrix metalloproteinase-9 (MMP-9) and adverse pregnancy outcome.
Poon LC, Nekrasova E, Anastassopoulos P, Livanos P, Nicolaides KH.
Prenatal Diagnosis 2009; 29: 553-559.
195Maternal serum placental growth factor (plgf) at 11+0 to 13+6 weeks of gestation in small for gestational age pregnancy.
Poon LC, Zaragoza E, Akolekar R, Anagnostopoulos E, Nicolaides KH.
Prenatal Diagnosis 2008; 28: 1110-1115.
196First trimester urinary placental growth factor and development of pre-eclampsia.
Savvidou M, Akolekar R, Zaragoza E, Poon L, Nicolaides KH.
BJOG 2009; 116: 643-647.
197First-trimester maternal serum tumor necrosis factor receptor-1 (TNF-R1) and preeclampsia.
Leal AM, Poon LC, Frisova V, Veduta A, Nicolaides KH.
Ultrasound in Obstetrics and Gynecology 2009; 33: 135-141.
198Maternal serum placental growth factor (plgf) at 11+0 to 13+6 weeks of gestation in hypertensive disorders of pregnancy.
Akolekar R, Zaragoza E, Poon LC, Pepes S, Nicolaides KH.
Ultrasound in Obstetrics and Gynecology 2008; 32: 732-739.
199Maternal serum placental growth factor (plgf) at 11+0-13+6 weeks in chromosomally abnormal pregnancies.
Zaragoza E, Akolekar R, Poon LC, Pepes S, Nicolaides KH.
Ultrasound in Obstetrics and Gynecology 2009; 33: 382-386.
200First-trimester maternal serum PAPP-A and preeclampsia.
Poon LC, Maiz N, Valencia C, Plasencia W, Nicolaides KH.
Ultrasound in Obstetrics and Gynecology 2009; 33: 23-33.
201Maternal serum ADAM12 (A Disintegrin And Metalloprotease) in chromosomally abnormal pregnancies at 11+0-13+6 weeks.
Poon LC, Chelemen T, Minekawa R, Frisova V, Nicolaides KH.
American Journal Obstetrics and Gynecology 2009; 200: 508.e1-6.
202First trimester maternal serum A Disintegrin And Metalloprotease 12 and adverse pregnancy outcome.
Poon LC, Chelemen T, Granvillano O, Pandeva I, Nicolaides KH.
Obstetric Gynecol 2008; 112: 1082-1090.
203Fetal Medicine Foundation Prolonged Pregnancy Group. Cervical length and maternal factors in expectantly managed prolonged pregnancy: prediction of onset of labor and mode of delivery.
Rao A, Celik E, Poggi S, Poon L, Nicolaides KH;
Ultrasound Obstet Gynecol 2008; 32: 646-651.
204Prediction of preeclampsia by a combination of maternal history, uterine artery doppler and mean arterial pressure.
Onwudiwe N, Yu CKH, Poon LC, Spiliopoulos I, Nicolaides KH.
Ultrasound Obstet Gynecol 2008; 32: 877-883.
205Uterine artery Doppler at 11+0-13+6 weeks and 21+0-24+6 weeks in the prediction of pre-eclampsia.
Plasencia W, Maiz N, Poon L, Yu C, Nicolaides KH.
Ultrasound Obstet Gynecol 2008; 32: 138-146.
206Inter-arm blood pressure differences in pregnant women.
Poon LC, Kametas N, Strobl I, Pachoumi C, Nicolaides KH.
BJOG 2008; 115: 1122-1130.
207Mean arterial pressure at 11+0-13+6 weeks in the prediction of pre-eclampsia.
Poon LC, Kametas N, Pandeva IV, Valencia CM, Nicolaides KH.
Hypertension 2008; 51: 1027-1033.
208Urine albumin concentration and albumin-to-creatinine ratio at 11+0-13+6 weeks in the prediction of pre-eclampsia.
Poon LC, Kametas N, Bonino S, Vercellotti E, Nicolaides KH.
BJOG 2008; 115: 866-873.
209Blood pressure levels correlate with intra-individual variability using an automated device in early pregnancy.
Poon LC, Kametas N, Valencia CM, Pandeva IV, Nicolaides KH.
J Hum Hypertens 2008; 22: 438-440.
210Tetralogy of Fallot in the fetus in the current era.
Poon LC, Huggon I, Zidere V and Allan LD.
Ultrasound Obstet Gynecol 2007; 29: 625-627.
211Audit of the effectiveness of cervical preparation with Dilapan prior to late second trimester (20-24 weeks) surgical termination of pregnancy.
Poon LC, Parsons J.
BJOG 2007; 114: 485-488.